The Genetics Podcast recap: Championing diversity and accessibility in genomics with Mavis Machirori
In the latest episode of the Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Mavis Machirori, a senior researcher at the Ada Lovelace...
Continue reading
Over the last two decades, following the landmark achievement of sequencing the first complete human genome, a suite of powerful genetic tools has emerged. Gene...
Continue reading
Precision medicine is an approach to treatment and prevention that accounts for individual differences in genes, environment, and lifestyle. It represents a shi...
Continue reading
Genetics now shapes how medicines are developed, how patients are diagnosed, and how clinical decisions are made. Yet a persistent gap exists between the pace o...
Continue reading
Genetic variation across populations has direct consequences for precision medicine trial design. As patient populations in clinical research become more ethnic...
Continue reading
Health equity, defined as everyone having the opportunity to be as healthy as possible, has long been a primary goal of public health. Still, across the world, ...
Continue reading
Our new whitepaper "Inclusive genomics: A path to equitable precision medicine" offers a close look at the intersection of genomic research and diversity. It's ...
Continue reading
Precision medicine marks a shift from the one-size-fits-all approach to healthcare to tailored treatments and interventions that account for an individual's uni...
Continue reading
Clinical trials are the foundation of modern medicine. They determine which treatments reach patients and how those treatments are understood. Yet for much of h...
Continue reading
Clinical trial populations consistently fail to reflect the demographics of the populations most affected by the diseases being studied. This gap is not simply ...
Continue reading